Alexander's disease (AD) is a rare neurodegenerative disorder, classified as a leukodystrophy and characterized by macrocephaly, psychomotor regression, spasticity, ataxia, and seizures 1 . Neuropathologically, it is diagnosed by the presence of perivascular, periventricular, brainstem, and cerebellar eosinophylic intra-astrocytic cytoplasmic inclusions, which are called Rosenthal fibres 1 . AD is caused by mutations in the gene encoding glial fibrillary acidic protein (GFAP) on chromosome 17qq21, with an autosomal dominant inheritance [1] [2] [3] . The aim was to describe a female young patient with progressive cerebellar ataxia as the first manifestation of AD.
A 13-year-old female was investigated because of a fouryear history of progressive gait disorder and incoordination. These progressive symptoms were accompanied by dysarthria, poor balance, and poor academic performance. Neurological examination showed mild cognitive impairment (MMSE=20), dysarthria, horizontal and vertical gazeevoked nystagmus, and gait ataxia. Brain magnetic resonance image (MRI) showed bilateral symmetric leukoencephalopathy, with frontal preponderance, without signal changes in the cerebellum (Figure) . The patient was evaluated in another neurological service and she had an extensive work up, including anti-gliadin, anti-peroxidase, anti-thyroglobulin, and anti-GAD antibodies, spinal cord MRI, electroneuromyography, sural nerve biopsy, and tests for inherited metabolic disorders, including very long-chain fatty acid, arysulfatase A and beta-galactosidase activity test. These were all normal. Re-evaluation of brain MRI suggested the diagnosis of AD. Molecular genetic test confirmed a heterozygous mutation (D157N) in the exons 2 and 8 (M4151) in the GFAP gene. The patien's mother was diagnosed with multiple sclerosis, treated with steroids and interferon. She had cerebellar ataxia and spasticity in the legs, and the brain MRI showed white matter abnormalities predominantly in both frontal lobes. She has a heterozygous mutation (M4151) in the exon 8 in the GFAP gene, confirming that she also had AD. AD is divided into three different forms: typical infantile form, with onset before two years of age and rapidly lethal course; juvenile form, with onset between 2 and 12 years of age, with slower progression; adult-onset form, with onset after the age of 12 years, or during adulthood, with predominant involvement of the brainstem, with bulbar or pseudobulbar symptoms, such as dysarthria, dysphagia, pyramidal signs, palatal myoclonus, and cerebellar ataxia 1 . MRI in early onset of AD is characterized by supratentorial periventricular white matter abnormalities, particularly in the frontal lobes. In adult-onset cases, MRI is often characterized by atrophy and signal abnormalities in the medulla oblongata and upper spinal cord 1, 3 . Juvenile AD represents 17.8 to 24.2% of the total cases, and it is the least common form of the disease. It represents a continuum between the infantile form, with cortical and subcortical signs, and the adult one with cerebellar and brainstem signs 1, 4 . Yoshida et al. 4 proposed a new clinical guideline for diagnosis of AD, including AD type 1, or cerebral AD, type 2, or bulbospinal AD, and type 3 or intermediate form of AD. This should be included in the differential diagnosis of cerebellar ataxia, with early and late onsets, in sporadic and hereditary cases 1, 5 . Delnooz et al. 5 described two sibs with AD, hereditary late-onset ataxia, and only minimal white matter changes. The phenotypic spectrum of AD was enlarged after the definition of the molecular genetic diagnosis with GFAP analysis [1] [2] [3] [4] [5] .
